|
Volumn 13, Issue 2, 1996, Pages 153-157
|
Treatment of Gaucher disease with an enzyme inhibitor
|
Author keywords
Gaucher disease chemotherapy; Glucosylceramidase insufficiency; Glucosylceramide synthase inhibition; PDMD (1 phenyl 2 decanoylamino 3 morpholino 1 propanol)
|
Indexed keywords
2 DECANOYLAMINO 3 MORPHOLINO 1 PHENYL 1 PROPANOL;
BETA GLUCOSIDASE;
CHLORPROMAZINE;
CYCLOSERINE;
ENZYME INHIBITOR;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ARTICLE;
CONTROLLED STUDY;
DRUG DISTRIBUTION;
DRUG METABOLISM;
FISH;
GAUCHER DISEASE;
HUMAN;
INTRAPERITONEAL DRUG ADMINISTRATION;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
ANIMALS;
CELLS, CULTURED;
ENZYME INHIBITORS;
FISHES;
GAUCHER DISEASE;
GLUCOSYLCERAMIDASE;
HUMANS;
MICE;
MORPHOLINES;
RATS;
|
EID: 0029939988
PISSN: 02820080
EISSN: None
Source Type: Journal
DOI: 10.1007/BF00731489 Document Type: Article |
Times cited : (112)
|
References (22)
|